𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Preclinical Safety Assessment of the Recombinant TNF Receptor–Immunoglobulin Fusion Protein

✍ Scribed by Michael Winter

Book ID
112240947
Publisher
Elsevier Science
Year
1997
Tongue
English
Weight
78 KB
Volume
83
Category
Article
ISSN
1090-2341

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Control of established experimental alle
Control of established experimental allergic encephalomyelitis by inhibition of tumor necrosis factor (TNF) activity within the central nervous system using monoclonal antibodies and TNF receptor-immunoglobulin fusion proteins
✍ David Baker; Debra Butler; Bernard J. Scallon; Janet K. O'Neill; John L. Turk; M 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 1018 KB

## Abstract Tumor necrosis factor (TNF) activity was inhibited during the development of actively‐induced, chronic relapsing experimental allergic encephalomyelitis (CREAE) in Biozzi AB/H mice, using a mouse TNF‐specific (TN3.19.12) antibody and bivalent human p55 and p75 TNF receptor‐immunoglobuli